HEADER TRANSPORT 27-JUN-03 1OIZ TITLE THE MOLECULAR BASIS OF VITAMIN E RETENTION: STRUCTURE OF TITLE 2 HUMAN ALPHA-TOCOPHEROL TRANSFER PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-TOCOPHEROL TRANSFER PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ALPHA-TTP, TTPA, TPP1; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: CONTAINS CRAL_TRIO LIPID BINDING DOMAIN, RESIDUES COMPND 7 89-275 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET-28A KEYWDS TRANSPORT, ATAXIA, AVED, TRANSFER PROTEIN, TOCOPHEROL, VITAMIN E EXPDTA X-RAY DIFFRACTION AUTHOR R.MEIER,T.TOMIZAKI,C.SCHULZE-BRIESE,U.BAUMANN,A.STOCKER REVDAT 3 13-JUL-11 1OIZ 1 VERSN REVDAT 2 24-FEB-09 1OIZ 1 VERSN REVDAT 1 14-JAN-04 1OIZ 0 JRNL AUTH R.MEIER,T.TOMIZAKI,C.SCHULZE-BRIESE,U.BAUMANN,A.STOCKER JRNL TITL THE MOLECULAR BASIS OF VITAMIN E RETENTION: STRUCTURE OF JRNL TITL 2 HUMAN ALPHA-TOCOPHEROL TRANSFER PROTEIN JRNL REF J.MOL.BIOL. V. 331 725 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 12899840 JRNL DOI 10.1016/S0022-2836(03)00724-1 REMARK 2 REMARK 2 RESOLUTION. 1.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 51495 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2711 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.88 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.93 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3689 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE SET COUNT : 194 REMARK 3 BIN FREE R VALUE : 0.3220 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4289 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 150 REMARK 3 SOLVENT ATOMS : 294 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.64000 REMARK 3 B22 (A**2) : -0.95000 REMARK 3 B33 (A**2) : 2.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.21000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.143 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.131 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.099 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.367 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4557 ; 0.010 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6177 ; 1.281 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 527 ; 5.605 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 667 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3396 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2298 ; 0.219 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 305 ; 0.121 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 54 ; 0.186 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.125 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2653 ; 0.534 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4299 ; 1.002 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1904 ; 1.598 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1878 ; 2.621 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 15 A 270 4 REMARK 3 1 B 15 B 270 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 9 A 273 REMARK 3 ORIGIN FOR THE GROUP (A): 40.7670 8.2050 51.6150 REMARK 3 T TENSOR REMARK 3 T11: 0.1313 T22: 0.1223 REMARK 3 T33: 0.0100 T12: -0.0194 REMARK 3 T13: 0.0218 T23: 0.0245 REMARK 3 L TENSOR REMARK 3 L11: 1.6550 L22: 2.8040 REMARK 3 L33: 1.0324 L12: 0.4627 REMARK 3 L13: 0.0890 L23: -0.1046 REMARK 3 S TENSOR REMARK 3 S11: 0.0344 S12: -0.1964 S13: 0.0316 REMARK 3 S21: 0.3012 S22: 0.0095 S23: 0.0923 REMARK 3 S31: 0.1174 S32: -0.0616 S33: -0.0439 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 11 B 274 REMARK 3 ORIGIN FOR THE GROUP (A): 22.4280 -5.5910 21.1560 REMARK 3 T TENSOR REMARK 3 T11: 0.1235 T22: 0.0988 REMARK 3 T33: 0.0256 T12: 0.0070 REMARK 3 T13: 0.0329 T23: -0.0215 REMARK 3 L TENSOR REMARK 3 L11: 2.0282 L22: 2.4580 REMARK 3 L33: 0.9050 L12: -0.1986 REMARK 3 L13: 0.3300 L23: 0.3537 REMARK 3 S TENSOR REMARK 3 S11: 0.0041 S12: 0.2584 S13: -0.0196 REMARK 3 S21: -0.2459 S22: -0.0445 S23: 0.0045 REMARK 3 S31: -0.2017 S32: 0.0723 S33: 0.0404 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OIZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-JUN-03. REMARK 100 THE PDBE ID CODE IS EBI-12944. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54206 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.880 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.88 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.44300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5% PEG 6000, 0.1 M HEPES REMARK 280 PH 7.5, 15% (V/V) MPD REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 56.88750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK 300 DETAILS:THE TWO MOLECULES IN THIS STRUCTURE HAVE REMARK 300 TRT MOLECULESAT THE INTERFACE AND HAVE A BURIED REMARK 300 SURFACE AREA OFOF 961.2 ANGSTROM**2 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 FUNCTION: BINDS ALPHA-TOCOPHEROL AND ENHANCES ITS TRANSFER REMARK 400 BETWEEN SEPARATE MEMBRANES. REMARK 400 DISEASE: DEFECTS IN TTPA ARE THE CAUSE OF ATAXIA WITH ISOLATED REMARK 400 VITAMIN E DEFICIENCY REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLU A 3 REMARK 465 ALA A 4 REMARK 465 ARG A 5 REMARK 465 SER A 6 REMARK 465 GLN A 7 REMARK 465 PRO A 8 REMARK 465 GLU A 275 REMARK 465 SER A 276 REMARK 465 ILE A 277 REMARK 465 GLN A 278 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 GLU B 3 REMARK 465 ALA B 4 REMARK 465 ARG B 5 REMARK 465 SER B 6 REMARK 465 GLN B 7 REMARK 465 PRO B 8 REMARK 465 SER B 9 REMARK 465 ALA B 10 REMARK 465 SER B 276 REMARK 465 ILE B 277 REMARK 465 GLN B 278 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 274 CA C O CB OG REMARK 470 GLU B 275 CA C O CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR B 117 C7 TRT B 1277 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG A 90 CZ ARG A 90 NH1 0.081 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 90 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 44 63.99 -10.43 REMARK 500 PHE A 61 19.49 56.96 REMARK 500 ASP A 185 29.95 -149.24 REMARK 500 SER A 272 2.36 -55.58 REMARK 500 ALA B 38 -23.53 66.58 REMARK 500 LEU B 42 -95.39 -35.93 REMARK 500 ALA B 43 74.80 -151.51 REMARK 500 ASP B 185 30.46 -151.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA B 43 PRO B 44 147.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRT A1274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRT A1275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRT A1276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRT B1275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRT B1276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRT B1277 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OIP RELATED DB: PDB REMARK 900 THE MOLECULAR BASIS OF VITAMIN E RETENTION: REMARK 900 STRUCTURE OF HUMAN ALPHA-TOCOPHEROL REMARK 900 TRANSFER PROTEIN REMARK 900 RELATED ID: 1R5L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-TOCOPHEROL REMARK 900 TRANSFERPROTEIN BOUND TO ITS LIGAND DBREF 1OIZ A 1 278 UNP P49638 TTPA_HUMAN 1 278 DBREF 1OIZ B 1 278 UNP P49638 TTPA_HUMAN 1 278 SEQRES 1 A 278 MET ALA GLU ALA ARG SER GLN PRO SER ALA GLY PRO GLN SEQRES 2 A 278 LEU ASN ALA LEU PRO ASP HIS SER PRO LEU LEU GLN PRO SEQRES 3 A 278 GLY LEU ALA ALA LEU ARG ARG ARG ALA ARG GLU ALA GLY SEQRES 4 A 278 VAL PRO LEU ALA PRO LEU PRO LEU THR ASP SER PHE LEU SEQRES 5 A 278 LEU ARG PHE LEU ARG ALA ARG ASP PHE ASP LEU ASP LEU SEQRES 6 A 278 ALA TRP ARG LEU LEU LYS ASN TYR TYR LYS TRP ARG ALA SEQRES 7 A 278 GLU CYS PRO GLU ILE SER ALA ASP LEU HIS PRO ARG SER SEQRES 8 A 278 ILE ILE GLY LEU LEU LYS ALA GLY TYR HIS GLY VAL LEU SEQRES 9 A 278 ARG SER ARG ASP PRO THR GLY SER LYS VAL LEU ILE TYR SEQRES 10 A 278 ARG ILE ALA HIS TRP ASP PRO LYS VAL PHE THR ALA TYR SEQRES 11 A 278 ASP VAL PHE ARG VAL SER LEU ILE THR SER GLU LEU ILE SEQRES 12 A 278 VAL GLN GLU VAL GLU THR GLN ARG ASN GLY ILE LYS ALA SEQRES 13 A 278 ILE PHE ASP LEU GLU GLY TRP GLN PHE SER HIS ALA PHE SEQRES 14 A 278 GLN ILE THR PRO SER VAL ALA LYS LYS ILE ALA ALA VAL SEQRES 15 A 278 LEU THR ASP SER PHE PRO LEU LYS VAL ARG GLY ILE HIS SEQRES 16 A 278 LEU ILE ASN GLU PRO VAL ILE PHE HIS ALA VAL PHE SER SEQRES 17 A 278 MET ILE LYS PRO PHE LEU THR GLU LYS ILE LYS GLU ARG SEQRES 18 A 278 ILE HIS MET HIS GLY ASN ASN TYR LYS GLN SER LEU LEU SEQRES 19 A 278 GLN HIS PHE PRO ASP ILE LEU PRO LEU GLU TYR GLY GLY SEQRES 20 A 278 GLU GLU PHE SER MET GLU ASP ILE CYS GLN GLU TRP THR SEQRES 21 A 278 ASN PHE ILE MET LYS SER GLU ASP TYR LEU SER SER ILE SEQRES 22 A 278 SER GLU SER ILE GLN SEQRES 1 B 278 MET ALA GLU ALA ARG SER GLN PRO SER ALA GLY PRO GLN SEQRES 2 B 278 LEU ASN ALA LEU PRO ASP HIS SER PRO LEU LEU GLN PRO SEQRES 3 B 278 GLY LEU ALA ALA LEU ARG ARG ARG ALA ARG GLU ALA GLY SEQRES 4 B 278 VAL PRO LEU ALA PRO LEU PRO LEU THR ASP SER PHE LEU SEQRES 5 B 278 LEU ARG PHE LEU ARG ALA ARG ASP PHE ASP LEU ASP LEU SEQRES 6 B 278 ALA TRP ARG LEU LEU LYS ASN TYR TYR LYS TRP ARG ALA SEQRES 7 B 278 GLU CYS PRO GLU ILE SER ALA ASP LEU HIS PRO ARG SER SEQRES 8 B 278 ILE ILE GLY LEU LEU LYS ALA GLY TYR HIS GLY VAL LEU SEQRES 9 B 278 ARG SER ARG ASP PRO THR GLY SER LYS VAL LEU ILE TYR SEQRES 10 B 278 ARG ILE ALA HIS TRP ASP PRO LYS VAL PHE THR ALA TYR SEQRES 11 B 278 ASP VAL PHE ARG VAL SER LEU ILE THR SER GLU LEU ILE SEQRES 12 B 278 VAL GLN GLU VAL GLU THR GLN ARG ASN GLY ILE LYS ALA SEQRES 13 B 278 ILE PHE ASP LEU GLU GLY TRP GLN PHE SER HIS ALA PHE SEQRES 14 B 278 GLN ILE THR PRO SER VAL ALA LYS LYS ILE ALA ALA VAL SEQRES 15 B 278 LEU THR ASP SER PHE PRO LEU LYS VAL ARG GLY ILE HIS SEQRES 16 B 278 LEU ILE ASN GLU PRO VAL ILE PHE HIS ALA VAL PHE SER SEQRES 17 B 278 MET ILE LYS PRO PHE LEU THR GLU LYS ILE LYS GLU ARG SEQRES 18 B 278 ILE HIS MET HIS GLY ASN ASN TYR LYS GLN SER LEU LEU SEQRES 19 B 278 GLN HIS PHE PRO ASP ILE LEU PRO LEU GLU TYR GLY GLY SEQRES 20 B 278 GLU GLU PHE SER MET GLU ASP ILE CYS GLN GLU TRP THR SEQRES 21 B 278 ASN PHE ILE MET LYS SER GLU ASP TYR LEU SER SER ILE SEQRES 22 B 278 SER GLU SER ILE GLN HET TRT A1274 25 HET TRT A1275 25 HET TRT A1276 25 HET TRT B1275 25 HET TRT B1276 25 HET TRT B1277 25 HETNAM TRT FRAGMENT OF TRITON X-100 HETSYN TRT 1-{2-[2-(2-METHOXYETHOXY)ETHOXY]ETHOXY}-4-(1, HETSYN 2 TRT 1,3,3-TETRAMETHYLBUTYL)BENZENE FORMUL 3 TRT 6(C21 H36 O4) FORMUL 9 HOH *294(H2 O) HELIX 1 1 SER A 9 ALA A 16 1 8 HELIX 2 2 SER A 21 LEU A 23 5 3 HELIX 3 3 LEU A 24 ALA A 38 1 15 HELIX 4 4 THR A 48 ARG A 59 1 12 HELIX 5 5 ASP A 62 CYS A 80 1 19 HELIX 6 6 CYS A 80 ALA A 85 1 6 HELIX 7 7 HIS A 88 SER A 91 5 4 HELIX 8 8 ILE A 92 ALA A 98 1 7 HELIX 9 9 ALA A 120 TRP A 122 5 3 HELIX 10 10 THR A 128 VAL A 144 1 17 HELIX 11 11 GLU A 146 GLY A 153 1 8 HELIX 12 12 GLN A 164 PHE A 169 1 6 HELIX 13 13 THR A 172 ASP A 185 1 14 HELIX 14 14 PRO A 200 LYS A 211 1 12 HELIX 15 15 ILE A 218 GLU A 220 5 3 HELIX 16 16 TYR A 229 PHE A 237 1 9 HELIX 17 17 PRO A 242 GLY A 246 5 5 HELIX 18 18 SER A 251 SER A 266 1 16 HELIX 19 19 SER A 266 SER A 272 1 7 HELIX 20 20 GLY B 11 ALA B 16 1 6 HELIX 21 21 SER B 21 LEU B 23 5 3 HELIX 22 22 LEU B 24 GLU B 37 1 14 HELIX 23 23 THR B 48 ARG B 59 1 12 HELIX 24 24 ASP B 62 CYS B 80 1 19 HELIX 25 25 CYS B 80 ALA B 85 1 6 HELIX 26 26 HIS B 88 SER B 91 5 4 HELIX 27 27 ILE B 92 GLY B 99 1 8 HELIX 28 28 ALA B 120 TRP B 122 5 3 HELIX 29 29 THR B 128 VAL B 144 1 17 HELIX 30 30 GLU B 146 GLY B 153 1 8 HELIX 31 31 GLN B 164 GLN B 170 1 7 HELIX 32 32 THR B 172 ASP B 185 1 14 HELIX 33 33 PRO B 200 LYS B 211 1 12 HELIX 34 34 ILE B 218 GLU B 220 5 3 HELIX 35 35 TYR B 229 PHE B 237 1 9 HELIX 36 36 PRO B 242 GLY B 246 5 5 HELIX 37 37 SER B 251 SER B 266 1 16 HELIX 38 38 SER B 266 ILE B 273 1 8 SHEET 1 AA 5 HIS A 101 VAL A 103 0 SHEET 2 AA 5 LYS A 113 ARG A 118 -1 O ILE A 116 N GLY A 102 SHEET 3 AA 5 ILE A 154 ASP A 159 1 O LYS A 155 N LEU A 115 SHEET 4 AA 5 VAL A 191 ILE A 197 1 N ARG A 192 O ILE A 154 SHEET 5 AA 5 ILE A 222 MET A 224 1 O HIS A 223 N LEU A 196 SHEET 1 BA 5 HIS B 101 VAL B 103 0 SHEET 2 BA 5 LYS B 113 ARG B 118 -1 O ILE B 116 N GLY B 102 SHEET 3 BA 5 ILE B 154 ASP B 159 1 O LYS B 155 N LEU B 115 SHEET 4 BA 5 VAL B 191 ILE B 197 1 N ARG B 192 O ILE B 154 SHEET 5 BA 5 ILE B 222 MET B 224 1 O HIS B 223 N LEU B 196 LINK OG SER A 140 C4 TRT A1275 1555 1555 1.91 SITE 1 AC1 11 TRP A 163 PHE A 165 ALA A 168 ILE A 202 SITE 2 AC1 11 PHE A 203 VAL A 206 ILE A 222 MET A 224 SITE 3 AC1 11 TRT A1276 HOH A2146 PHE B 213 SITE 1 AC2 9 LEU A 115 TYR A 117 SER A 136 SER A 140 SITE 2 AC2 9 ILE A 143 ILE A 154 VAL A 182 LEU A 189 SITE 3 AC2 9 VAL A 191 SITE 1 AC3 7 TRP A 163 ALA A 168 ILE A 171 TRT A1274 SITE 2 AC3 7 VAL B 206 MET B 209 TRT B1276 SITE 1 AC4 6 PHE B 165 ILE B 202 VAL B 206 ILE B 222 SITE 2 AC4 6 MET B 224 TRT B1276 SITE 1 AC5 7 MET A 209 ILE A 210 TRT A1276 ILE B 179 SITE 2 AC5 7 TRT B1275 TRT B1277 HOH B2148 SITE 1 AC6 18 TYR B 100 LEU B 115 TYR B 117 ILE B 119 SITE 2 AC6 18 VAL B 132 PHE B 133 SER B 136 SER B 140 SITE 3 AC6 18 ILE B 154 ALA B 156 PHE B 158 ILE B 171 SITE 4 AC6 18 ILE B 179 LEU B 183 LEU B 189 VAL B 191 SITE 5 AC6 18 TRT B1276 HOH B2091 CRYST1 45.144 113.775 67.433 90.00 98.95 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022151 0.000000 0.003489 0.00000 SCALE2 0.000000 0.008789 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015012 0.00000